EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Significance of Aspergillus sp Found in Respiratory Fungal Cultures of ICU Patients

Katriina Pihlajamaa iD, Maija Halme iD, Miia Valkonen, Veli-Jukka Anttila iD

Journal of Intensive Care Medicine · 2025

DOI: 10.1177/08850666251340043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Intensive Care Medicine, 2025. Verfasst von Katriina Pihlajamaa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Heart and Lung Center, Helsinki University Central Hospital, Helsinki, Finland. Hauptthemen laut MEDLINE: Intensive Care Units, Aspergillus, Invasive Pulmonary Aspergillosis. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suomen Tuberkuloosin Vastustamisyhdistyksen Säätiö, Tampereen Tuberkuloosisäätiö, Väinö ja Laina Kiven Säätiö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Invasive pulmonary aspergillosis (IPA) is a very severe manifestation of Aspergillus disease. Besides well-known risk groups of deeply neutropenic hematologic and solid organ transplant recipients other risk groups among patients treated in ICUs have been recognized. The prevalence of IPA among ICU-patients is not known and it is not known how well IPA is recognized in ICU-settings. The diagnosis of IPA is often difficult to make and non-invasive ways to diagnose IPA reliably are needed.

Objectives

In this study we studied the clinical significance of Aspergillus -positive respiratory samples in ICU-patients.

Methods

We retrospectively evaluated the ICU-patients (N = 205) who provided Aspergillus -positive respiratory samples in 2007-2020 and classified patients to groups of “colonization”, “putative IPA”, “proven IPA “, as in AspICU algorithm. Data were collected from laboratory registry and Helsinki University Hospital medical records. Underlying conditions, reasons leading to treatment in ICU, immunosuppression, known risk factors of IA in ICU, signs of infection, results of Aspergillus -specific laboratory testing, use of antifungal treatment, survival, and reason of death were assessed.

Results

Majority of the findings (63%) were colonization, 11 (5%) patients had proven IPA, and “putative IPA” 59 (29%) of the patients. All patients with proven IPA died within one year, whereas mortality in putative and colonization groups was 39% and 33% respectively. Difference in mortality during one year between “colonization” and “putative IPA” groups was not statistically significant (p = .244), but when both “proven” and “putative” IPA were included, the difference was statistically significant, p = .019. Overall hospital mortality in the study group was 38%. Mortality in all the groups is higher than overall ICU-patient mortality of non-selected patients in Finland.

Conclusions

The overall incidence of Aspergillus -findings in our ICUs was low. Isolation of Aspergillus in critically ill is associated with high mortality irrespective of invasion or colonization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intensive Care UnitsAspergillusInvasive Pulmonary AspergillosisHumansMaleRetrospective StudiesFemaleMiddle AgedAgedRisk FactorsFinlandAdultAntifungal AgentsClinical Relevance

Stichwörter der Autor:innen

aspergillus colonizationdiagnostic algorithmfungal culturesinvasive pulmonary aspergillosis

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Heart and Lung Center, Helsinki University Central Hospital, Helsinki, Finland.
  • University of Helsinki, Helsinki, Finland.
  • Department of Perioperative, Intensive Care and Pain Medicine, Intensive Care Medicine, Helsinki University Central Hospital, Helsinki, Finland.
  • Inflammation Center, Helsinki University Central Hospital, Helsinki, Finland.

ORCID-Profile: Katriina Pihlajamaa, Maija Halme, Veli-Jukka Anttila

Förderung

  • Suomen Tuberkuloosin Vastustamisyhdistyksen Säätiö
  • Tampereen Tuberkuloosisäätiö
  • Väinö ja Laina Kiven Säätiö

Zitieren

APA

Pihlajamaa, K., Halme, M., Valkonen, M., & Anttila, V. J. (2025). Clinical Significance of Aspergillus sp Found in Respiratory Fungal Cultures of ICU Patients. Journal of Intensive Care Medicine. https://doi.org/10.1177/08850666251340043

Vancouver

Pihlajamaa K, Halme M, Valkonen M, Anttila VJ. Clinical Significance of Aspergillus sp Found in Respiratory Fungal Cultures of ICU Patients. Journal of Intensive Care Medicine. 2025. doi:10.1177/08850666251340043

BibTeX
@article{Pihlajamaa2025,
  author = {Pihlajamaa, Katriina and Halme, Maija and Valkonen, Miia and Anttila, Veli-Jukka},
  title = {Clinical Significance of Aspergillus sp Found in Respiratory Fungal Cultures of ICU Patients},
  journal = {Journal of Intensive Care Medicine},
  year = {2025},
  doi = {10.1177/08850666251340043}
}
Kostenlos starten →